This medication is an ACE (angiotensin-converting enzyme) inhibitor, prescribed for high blood pressure either alone or with other medications. This medication is an angiotensin converting enzyme ...

A recent study suggests that a commonly prescribed type of blood pressure medication, known as angiotensin receptor blockers ...

Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals ...

The criteria selected ( Table I ) to evaluate the drug entities within the ACEI class were as follows: clinical efficacy (score 345 points); lack of adverse effects (185 points); lack of ...

One surprising finding was that a specific group of calcium channel blockers, known as the non-dihydropyridine class, appeared to be connected to a higher risk of bowel conditions, including ...

For patients who are intolerant of ACE inhibitors, alternative medications are available. The combination of hydralazine and nitrates also decreases mortality for patients with systolic ...

Methods: The modified SOJA approach involved four phases in sequence: an evidence-based pharmacotherapeutic evaluation of all available ACEI drug entities, a separate safety/risk assessment ...